Molecular epidemiology of vancomycin-resistant enterococcal bacteraemia: Results from the canadian nosocomial infection surveillance program, 1999-2009

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 7, 2013, Pages 1505-1509

  McCracken, M ^a   Wong, A ^b   Mitchell, R ^c   Gravel, D ^c   Conly, J ^d   Embil, John ^e   Johnston, L ^f,r   Matlow, A ^g   Ormiston, D ^e   Simor, A E ^h   Smith, Stephanie ^i,af   Du, T ^a   Hizon, R ^a   Mulvey, Michael ^a   Boyd, David ^a   Bridger, Natalie ^j   Bryce, Elizabeth ^k   Dascal, André ^l   de Heer, Janice ^m   Embree, Joanne ^e   Evans, Gerald ⁿ   Forgie, Sarah ^o   Frenette, Charles ^p   Haldane, David ^f   German, Gregory ^q   Golding, George ^a   Hembroff, Deanna ^r   Henderson, Elizabeth ^s   John, Michael ^t   Katz, Kevin ^u   Kibsey, Pamela ^v   Kuhn, Magdalena ^w   Langley, Joanne ^x   Lemieux, Camille ^y   Le Saux, Nicole ^z   Loeb, Mark ^aa   Richardson, Susan ^g   McGeer, Allison ^ab   Mertz, Dominik ^aa   Miller, Mark ^l   Moore, Dorothy ^ac   Pelletier, Suzanne ^ad   Pelude, Linda ^c   Quach, Caroline ^ac   Roth, Virginia ^ad   Suh, Kathryn ^ae   Taylor, Geoffrey ^af   Thomas, Eva ^ag   Turgeon, Nathalie ^ah   Vearncombe, Mary ^h   Vayalumkal, Joseph ^ai   Weiss, Karl ^aj   more..

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b ROYAL UNIVERSITY HOSPITAL   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e HEALTH SCIENCES CENTRE   (Canada)

^f QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h SUNNYBROOK RESEARCH INSTITUTE   (Canada)

ⁱ UNIVERSITY OF ALBERTA   (Canada)

^j Eastern Health Canada   (Canada)

^k VANCOUVER GENERAL HOSPITAL   (Canada)

^l MCGILL UNIVERSITY   (Canada)

^m Interior Health Authority   (Canada)

ⁿ KINGSTON GENERAL HOSPITAL   (Canada)

^o STOLLERY CHILDREN S HOSPITAL   (Canada)

^p MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^q Prince Edward Island   (Canada)

^r University of Northern   (Canada)

^s ALBERTA HEALTH SERVICES   (Canada)

^t LONDON HEALTH SCIENCES CENTRE   (Canada)

^u NORTH YORK GENERAL HOSPITAL   (Canada)

^v VICTORIA GENERAL HOSPITAL   (Canada)

^w IWK Health Centre ^*  (Canada)

^x IWK HEALTH CENTRE   (Canada)

^y UNIVERSITY HEALTH NETWORK   (Canada)

^z CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^aa HAMILTON HEALTH SCIENCES   (Canada)

^ab MOUNT SINAI HOSPITAL   (Canada)

^ac MONTREAL CHILDREN S HOSPITAL   (Canada)

^ad HEALTH SCIENCES NORTH   (Canada)

^ae UNIVERSITY OF OTTAWA   (Canada)

^af UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^ag CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^ah LAVAL UNIVERSITY   (Canada)

^ai ALBERTA CHILDREN'S HOSPITAL   (Canada)

^aj MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

more..

Author keywords

CC17; E. faecium; MLST; vanA; Vancomycin resistant enterococcus

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; NITROFURANTOIN; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE; TIGECYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BROTH DILUTION; CANADA; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; VANCOMYCIN RESISTANT ENTEROCOCCAL BACTEREMIA; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 84879493683     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt054     Document Type: Article

References (20)

1. Uttley AH, Collins CH, Naidoo J et al. Vancomycin-resistant enterococci. Lancet 1988; i: 57-8.
2. Bonten MJ, Willems RJ, Weinstein RA. Vancomycin-5resistant enterococci: why are they here, and where do they come from?. Lancet Infect Dis 2001; 1: 314-25.
3. Deshpande LM, Fritsche TR, Moet GJ et al. Antimicrobial resistance and molecular epidemiology of vancomycin-resistance enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 2007; 58: 163-70.
4. Lu C-L, Chuang Y-C, Chang H-C et al. Microbiological and clinical characteristics of vancomycin-resistant Enterococcus faecium bacteraemia in Taiwan: implication of sequence type for prognosis. J Antimicrob Chemother 2012; 67: 2243-9.
5. Denkinger CM, Grant AD, Denkinger M et al. Increased multi-drug resistance among the elderly on admission to the hospital-a 12-year surveillance study. Arch Gerontol Geriatr 2012; 56: 227-30.
6. Currie BP, Gnass S, Levi MH. A hospital based stool culture survey to detect vancomycin resistant enterococcus (VRE)-utility and application. Infect Control Hosp Epidemiol 1995; 16 Suppl: P18 (Abstract 15).
7. National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001. Am J Infect Control 2001; 29: 404-21.
8. Kibsey PC, Willey B, Low DE et al. Vancomycin multi-resistant Enterococcus faecium: first Canadian isolate. In: Abstracts of the Canadian Association for Clinical Microbiology and Infectious Diseases, Vancouver, BC, 1993. Abstract K5.
9. Ofner-Agostini ME, Conly J, Paton S et al. Vancomycin-resistant enterococci (VRE) in Canada-results of the Canadian Nosocomial Infection Surveillance Program 1996 VRE point prevalence surveillance project. Can J Infect Dis 1997; 8: 73-8.
10. Ofner-Agostini M, Johnston L, Simor AE et al. Vancomycin-resistant enterococci in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1999-2005. Infect Control Hosp Epidemiol 2008; 29: 271-4.
11. Zhanel GG, Adam HJ, Low DE et al. Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007-2009 study. Diagn Microbiol Infect Dis 2011; 69: 291-306.
12. Zhanel GG, DeCorby M, Laing N et al. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrob Agents Chemother 2008; 52: 1430-7.
13. Simor AE, Williams V, Larios O et al. Prevalence of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus and Clostridium difficile infection in Canadian hospitals. In: Abstracts of the Forty-ninth Annual Meeting of the Infectious Diseases Society of America, Boston, MA, 2011. Abstract 773.
14. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20. CLSI, Wayne, PA, USA, 2010.
15. Boyd DA, Willey BM, Fawcett D et al. Molecular characterization of Enterococcus faecalis N06-0364 with low-level vancomycin resistance harboring a novel D-Ala-D-Ser gene cluster, vanL. Antimicrob Agents Chemother 2008; 52: 2667-72.
16. Homan WL, Tribe D, Poznanski S et al. Multilocus sequence typing scheme for Enterococcus faecium. J Clin Microbiol 2002; 40: 1963-71.
17. Francisco AP, Bugalho M, Ramirez M et al. Global optimal eBURST analysis of multilocus typing data using a graphic matroid approach. BMC Bioinformatics 2009; 10: 152.
18. McKinnell JA, Patel M, Shirley RM et al. Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents. Epidemiol Infect 2011; 139: 1342-50.
19. Leavis HL, Willems RJL, van Wamel WJB et al. Insertion sequencedriven diversification creates a globally dispersed emerging multiresistant subspecies of E. faecium. PLoS Pathog 2007; 3: e7.
20. Rice LB, Carias L, Rudin S et al. A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin. J Infect Dis 2003; 187: 508-12.